Take cards for your nootropics brand, with nothing held back.
Processors treat even lawful nootropics as high risk, because the word has no legal meaning and some brands have hidden unapproved drugs in their capsules. Railbed takes your buyers’ cards for lawful stacks and settles every order to a wallet you control, with nothing held back.
- Nothing held back
- No setup fee
- Settled sales stay yours
Press the card to run an example sale.
- Settles to
- Your own wallet, as USDC on Polygon
- Chargebacks
- Settled sales can’t be pulled back. Card disputes go to the provider
- To start
- An email, your website and a payout wallet. No setup fee, no monthly fee
- Buyer ID checks
- Providers decide. Smart Routing picks the one least likely to ask
How can a nootropics brand accept credit card payments?
A nootropics brand can accept credit cards with a checkout that has no application to pass. Many nootropics are lawful to sell as dietary supplements, but processors file them with pseudo-pharmaceuticals, so brands meet reserves, document requests and sudden closures. Railbed takes your buyers’ cards through independent, licensed card providers and settles each order to a wallet you control, with no underwriting. Compounds such as phenibut, tianeptine and modafinil aren’t lawful supplements, and the law stays yours to follow.
Why nootropics brands get refused
A focus stack of L-theanine, caffeine and bacopa is an ordinary dietary supplement. Called a nootropic, it lands in the riskiest corner of a processor’s rulebook, next to research chemicals and pseudo-pharmaceuticals, and a brand selling nothing unlawful can lose its gateway over a word.
- $5.86 billionThe global nootropics market in 2025, forecast to pass $12 billion by 2034
- 4 of 5“Cognitive” supplement brands tested that contained the unapproved drug piracetam
- 5–10%The rolling reserve nutraceutical accounts often carry, held 90 to 180 days
…stating my site is selling ‘pseudo-pharmaceuticals’ and cannot use their payment gateway
The written rules are broad. Stripe’s prohibited businesses list bans “pseudo-pharmaceuticals or nutraceuticals that are not safe or make harmful claims” and “incorrectly labeled research chemicals”. PayPal’s acceptable use policy prohibits products “that present a risk to consumer safety” and needs approval for anything requiring a prescription. Shopify Payments restricts pseudo-pharmaceuticals. None of them names nootropics, and that’s the trouble: a reviewer decides. One seller on Shopify’s forum got “an email from a bot stating my site is selling ‘pseudo-pharmaceuticals’ and cannot use their payment gateway” (thread), with no product named.
The caution has a history. When researchers tested “cognitive” supplements in 2019, four of five brands contained piracetam, a drug FDA has said can’t be sold as a supplement, at doses up to 11,283 mg a day if buyers followed the label. FDA has also said phenibut “does not meet the statutory definition of a dietary ingredient”, and in one warning letter it treated a seller’s noopept, phenibut and even L-theanine as unapproved drugs because of the disease claims made for them. Twenty states now control tianeptine, sold as “gas station heroin”, LAPPA reports. A risk team can’t tell the lawful stack from the problem one at a glance, so it refuses both.
Specialists say so themselves.
What their own pages admit
- Legal isn’t enough. One nootropics page says “even legal nootropics are often treated as high-risk by banks and processors”.
- The word itself. Another notes that “the word nootropic has no legal meaning” and that cognitive claims are easy to push too far.
- The terms. One processor’s nootropics page now redirects to its general nutraceutical page, where terms run 1.95–4.95% plus per-authorisation fees, a reserve often of 5–10% held for months, and labels, lab results and website screenshots before a decision.
The card networks raise the stakes. A brand coded as a drug seller rather than a supplement seller lands in categories Visa and Mastercard make acquirers register, and Visa has flagged card-not-present merchants whose fraud and disputes pass 1.5% of transactions since April 2026. Autoship stacks that rebill buyers who forgot they signed up are the usual way a brand gets there.
How Railbed works for a nootropics brand
Railbed is card checkout for lawful nootropics brands that never holds your money. Buyers pay with the card they already have, and each order settles as USDC straight to a wallet you control, usually minutes after they pay. There’s no underwriting and no application to pass, and there’s no balance with Railbed for anyone to freeze.
| What goes wrong today | With Railbed |
|---|---|
| A bot flags your site as “pseudo-pharmaceuticals” and the gateway stops | No underwriting and no application to pass. Sign up with an email, your website and a payout wallet |
| Labels, lab results and screenshots before the first sale | Live in under a minute, with Test mode to try it first |
| A 5–10% rolling reserve held for months | Nothing is held back from your sales |
| Autoship rebills bring disputes from buyers who forgot | No automatic charges. Every order is one the buyer chooses |
| Each chargeback costs a fee and counts toward a 1.5% threshold | Settled sales can’t be pulled back from your wallet. Disputes go to the card provider that charged the card |
| One acquiring bank decides which buyers’ cards go through | Smart Routing sends each buyer to the card provider most likely to approve them |
An independent, licensed card provider charges the buyer’s card and buys USDC with it, and the USDC is forwarded to the Polygon wallet you saved in Railbed. Railbed checks that the right amount reached the right wallet before it marks the order paid.
Which compounds can be sold as supplements?
The answer depends on the compound, not on the word nootropic. Under US law a dietary supplement may contain only dietary ingredients, and FDA has said, compound by compound, that several of the best-known nootropics aren’t. A brand that keeps those out of its catalogue is selling supplements; a brand that sells them is selling something else, whatever the label says.
Where the best-known compounds stood on 20 November 2026, in the regulators’ own words:
| Compound | Its US status | Who says so |
|---|---|---|
| Phenibut | “Does not meet the definition of a dietary ingredient”, so supplements listing it are misbranded | FDA, April 2019 |
| Picamilon | “Does not meet the statutory definition of a dietary ingredient” | FDA, November 2015 |
| Piracetam | An unapproved drug that FDA has said can’t be sold as a supplement | JAMA Internal Medicine, 2019 |
| Tianeptine | “Not a dietary ingredient”, and an unsafe food additive | FDA, May 2025 |
| Modafinil | A Schedule IV controlled substance, sold only on prescription | 21 CFR 1308.14 |
| Bulk pure caffeine powder | In general adulterated when sold in bulk so the buyer must separate a safe serving from a potentially lethal amount | FDA guidance, April 2018 |
Caffeine shows how fine the line can be. Caffeine in a measured capsule is one of the most common ingredients in a focus stack, while FDA says “just one teaspoon of pure powdered caffeine can contain the same amount of caffeine as 28 cups of coffee”, and in April 2018 it told industry that it generally considers a bulk powder that leaves the buyer to separate a safe serving from a potentially lethal amount to be adulterated.
Railbed doesn’t check what you stock. Following FDA and state law for every ingredient in your catalogue is your job, and when a compound is in doubt, take advice from a lawyer who works with supplement brands.
Nootropics and the regulators, year by year
Nobody approves a supplement before it goes on sale, so the line around nootropics has been drawn afterwards, one compound and one warning letter at a time. The record below is why a processor’s risk team reads “nootropic” as a warning sign.
- 1994
The Dietary Supplement Health and Education Act sets the rules for structure/function claims on supplement labels.
- Nov 2015
FDA warns five companies that picamilon is not a dietary ingredient.
- Apr 2018
FDA tells industry that bulk pure caffeine leaving buyers to measure out a safe serving is, in general, adulterated.
- Nov 2018
FDA warns that tianeptine is not a dietary ingredient and is an unsafe food additive.
- Feb 2019
FDA and the FTC jointly warn a nootropics store over disease claims for its alpha-GPC, citicoline and piracetam pages.
- Apr 2019
FDA sends three warning letters to companies selling supplements labelled to contain phenibut.
- Nov 2019
Researchers find piracetam in four of five “cognitive” supplement brands they test.
- Feb 2022
FDA warns a seller whose noopept, phenibut and L-theanine pages made disease claims.
- May 2025
FDA reports poison centre cases involving tianeptine rose from 4 in 2013 to about 350 in 2024.
Two lessons run through it. The ingredient can make a product unlawful, as with phenibut and picamilon. And the words can do it on their own: the 2019 and 2022 letters named ordinary ingredients because of what the sellers’ pages said about them.
Where tianeptine is controlled, state by state
Tianeptine is the clearest case of a compound sold online as a mood or brain product that states have turned into a controlled drug. It isn’t controlled under federal law, but as of December 2025, the Legislative Analysis and Public Policy Association counted 14 states listing it in Schedule I, five in Schedule II, one in Schedule III, and Maryland banning its sale without scheduling it.
- Schedule I controlled substance14
- Alabama, Delaware, Florida, Georgia, Indiana, Kansas, Kentucky, Louisiana, Minnesota, Nebraska, Nevada, Ohio, Utah, Virginia. LAPPA
- Schedule II or III controlled substance6
- Arkansas, Michigan, Mississippi, North Carolina, Oklahoma, Tennessee. LAPPA
- Sale banned, not scheduled1
- Maryland. LAPPA
- Everywhere else30
- None of the rules above.
The map is LAPPA’s list from December 2025. State law changes, and checking it for every state you ship to is your job. The same fact sheet says Connecticut passed a law in June 2025 requiring its consumer protection commissioner to schedule tianeptine, and that bills were filed in 2025 in California, Maine, New Jersey, New York and Pennsylvania. In the states the map leaves plain, FDA’s position still applies everywhere: tianeptine isn’t a dietary ingredient.
For a nootropics brand the practical point is narrow. Tianeptine doesn’t belong in a supplement catalogue anywhere in the US, and a store that carries it next to lawful stacks gives every processor, marketplace and regulator a reason to treat the whole store as a drug seller.
What a nootropics page can say
Most nootropics brands that get into trouble get there through their copy, not their capsules. A supplement may carry a structure/function claim, one that describes how an ingredient affects the normal structure or function of the body, but not a claim that it treats or prevents a disease.
FDA’s rules for those claims are short. The firm must have substantiation that the claim is “truthful and not misleading”, must notify FDA of the claim’s text “no later than 30 days after marketing” the product with it, and must state that FDA hasn’t evaluated the claim and that the product is not intended to “diagnose, treat, cure or prevent any disease”, FDA explains.
The line is easy to cross on a brain product. In February 2019 FDA and the Federal Trade Commission sent a joint warning letter to a nootropics store that sold alpha-GPC, citicoline, lion’s mane and piracetam. The letter quoted pages saying one product “prevents cognitive decline (such as senile dementia and Alzheimer’s disease)”, and concluded that the claims made the products drugs. The letter didn’t rule on the ingredients themselves; a footnote says it does not address whether piracetam can be lawfully marketed as a supplement. The words were enough. Lion’s mane brands have the same problem, covered on our functional mushrooms page.
What that means for your store:
- Product pages. Describe what is in the product and how much. A disease named next to your product, in your copy or in a customer review you feature, can turn it into a drug in FDA’s eyes.
- Ads and social posts. The joint letter was signed by the FTC’s Division of Advertising Practices as well as FDA, so the copy that counts isn’t only the label.
- Product names. A name that promises a medical result makes the claim on every page, invoice and receipt it appears on.
Marketplaces close too
A marketplace listing is not a safe place to move a refused nootropics brand. Amazon’s drugs and drug paraphernalia policy prohibits substances “listed in Schedules I, II, III, or IV of the Controlled Substances Act, controlled by state law”, and products identified as “misbranded, misleading, unapproved” by FDA, DEA or the FTC. Its list of examples names “Celastrus paniculatus (in all forms)”, and it prohibits kratom outright, which our kratom page covers.
The result is that a nootropics brand’s own website is usually its main shop, and the checkout on that website is the one part of the business a payment company can switch off. Railbed sits there: your store, your product pages, and card payments that settle to a wallet you control.
How a sale works
A buyer chooses a three-month supply of your focus stack.
Railbed’s checkout asks for an email and the details you turned on, such as a delivery address. Smart Routing picks the card provider most likely to approve this buyer.
The buyer pays on the provider’s page, in a new tab. The provider decides whether to ask for identity details, and Smart Routing tries the providers least likely to ask first.
The provider buys USDC with the card payment and it’s forwarded to your wallet on Polygon. Railbed checks the amount and the wallet before it marks the order paid.
The paid order lands in your store or your Railbed dashboard, ready to ship.
Try the whole flow in Test mode first. Payments are simulated and no card is charged.
What you can sell, and what you can’t
Railbed’s acceptable use policy holds only the limits the law puts on Railbed itself. What goes in your capsules and on your pages is yours to get right:
- Lawful as supplements. Nutrients and botanicals such as L-theanine, caffeine in measured servings, citicoline, alpha-GPC, bacopa, rhodiola and lion’s mane, sold with honest labels and structure/function claims carrying the required disclaimer.
- Not lawful as supplements in the US. FDA says phenibut, picamilon and tianeptine aren’t dietary ingredients and that piracetam may not be sold as one. Modafinil and armodafinil are federal Schedule IV controlled substances that need a prescription, and twenty states control tianeptine. Those rules apply whichever checkout you use.
- Claims. Saying a product treats ADHD, dementia or any other disease makes it a drug in FDA’s eyes, whatever is in the capsule. A “research chemical” label doesn’t change what a product is if it’s sold for people to take.
Before your first order
None of this needs an application. It is the short list a nootropics brand gets right once, so that its checkout and its catalogue tell the same story.
A payout wallet. Save the Polygon wallet your sales should settle to. Use a wallet you hold the keys to, not an exchange deposit address.
An ingredient check. Go through your catalogue against FDA’s statements and remove anything it says isn’t a dietary ingredient, such as phenibut, picamilon or tianeptine.
Claim notifications. Send FDA the text of each structure/function claim within 30 days of first selling with it, and print the disclaimer wherever the claim appears.
A copy pass. Read every product page, ad and featured review for a disease named next to your product, and take it out.
Supplies, not autoship. Decide your one-, three- and six-month sizes and prices. Card providers have minimums, the smallest about $2, and around $10 or more gives buyers the widest choice.
A refund rule. Write down what your money-back guarantee covers and how you return the money, because Railbed can’t reverse a settled payment for you.
A run in Test mode. Buy each supply size in Test mode and watch the order reach your store before you take a Live payment.
Running Railbed beside the checkout you have
You don’t have to move the whole store at once. Nothing about Railbed is exclusive, and a nootropics brand usually adds it where its current checkout is weakest:
- For the products a processor flagged. If one stack or one ingredient triggered the review, sell that line through Railbed and leave the rest where it is.
- As the fallback. When your main checkout declines a card, offer Railbed on the same screen. A buyer turned away by one fraud screen is often approved by a different card provider.
- As the spare. A brand with two working checkouts keeps selling on the day one of them sends the “pseudo-pharmaceuticals” email.
Fulfil from the paid event either way, so your warehouse never needs to know which checkout took the money.
Fees and getting paid
Railbed shows every fee before anyone pays, and all of them come out of the USDC that arrives. The card provider takes its own fee and exchange spread, shown to the buyer on its page. Then come a 1% network fee and the Railbed fee, from 0.9%, shown in your dashboard and locked when the buyer starts paying. There’s no setup fee, no monthly fee and no chargeback fee.
Set prices in USD, EUR, GBP, CAD, AUD, INR or SEK. To pay your manufacturer from a bank account, send USDC from your wallet to any exchange or off-ramp you use and withdraw it there.
Refunds are your call. Railbed can’t reverse a settled payment, so to refund a buyer, send USDC back or agree another arrangement with them.
Guarantees, refunds and disputes
Money-back guarantees are common on focus stacks, because a buyer can’t know whether they like a blend until they’ve taken it for a few weeks. With Railbed the money from each order is already in your wallet, so honouring a guarantee is something you do, not something a processor does for you: return the USDC or agree another arrangement with the buyer.
A dispute works differently. The buyer’s bank raises it with the card provider that charged the card, under that provider’s terms and the card networks’ rules, and nothing comes out of your wallet. At a conventional processor the same dispute counts toward Visa’s 1.5% line. None of that makes a guarantee less useful: a buyer who can get a refund from you in a day has no reason to call their bank.
When Railbed is not the right fit
Railbed suits a nootropics brand selling lawful supplements that wants card payments without a category review. It is the wrong tool in a few cases:
- You sell compounds that aren’t lawful supplements. Phenibut, tianeptine, modafinil and anything else the law forbids are no more lawful through a different checkout, whatever the label says.
- Your model depends on autoship. Railbed never stores a card or charges one automatically. Multi-month supplies and reorder invoices replace it, and some buyers will let a supply run out.
- You want a merchant of record. With Railbed the sale is yours, and so are sales tax and VAT where you owe them.
- You never want to hold USDC. Sales settle as USDC to your wallet. Moving it to a bank through an exchange is a step you take yourself.
Railbed compared with a nootropics merchant account
| High-risk nutraceutical account | Railbed | |
|---|---|---|
| Approval | Days, after a label and ingredient review | Under a minute |
| To apply | Labels, lab results, website screenshots, statements | An email, your website and a payout wallet |
| Pricing | About 1.95–4.95%, plus per-authorisation and monthly fees | The card provider’s fee, a 1% network fee and the Railbed fee from 0.9%, shown before payment |
| Reserve | Often 5–10%, held 90 to 180 days | Nothing is held back from your sales |
| Repeat orders | Autoship rebills, and the disputes they bring | Multi-month supplies and invoices for reorders |
| Chargebacks | A fee for each, and thresholds from 1.5% | Settled sales can’t be pulled back. Disputes go to the card provider |
Words worth knowing
The terms a nootropics brand meets between its label, its regulator and its payment company.
- Dietary ingredient
- What a US supplement may contain. FDA has said phenibut, picamilon and tianeptine don’t qualify, so supplements listing them are unlawful.
- Structure/function claim
- A statement about how an ingredient affects the normal structure or function of the body. It needs substantiation, a notification to FDA within 30 days and a disclaimer.
- Disease claim
- A statement that a product diagnoses, treats, cures or prevents a disease. Only a drug may make one, so it turns a supplement into an unapproved drug.
- Pseudo-pharmaceutical
- A processor’s word for a product sold as if it worked like a medicine without being one. Policies use it without defining it, so a reviewer decides.
- Research chemical
- A compound labelled “not for human consumption”. The label doesn’t change what a product is when it’s sold for people to take.
- Controlled substance
- A drug listed in a federal or state schedule. Modafinil is federal Schedule IV; tianeptine is scheduled by 20 states.
- Rolling reserve
- A share of each sale a processor holds back for months against future disputes. Nutraceutical accounts often carry 5–10%.
Questions
Shopify Payments or Stripe flagged my nootropics as pseudo-pharmaceuticals. Can I use Railbed?
Yes. A flag, a closure or a MATCH listing doesn’t rule you out, and you don’t send labels, lab results or statements to sign up. Railbed Checkout for Shopify keeps your store where it is and turns each paid checkout into a Shopify order.
Are nootropics legal to sell?
Many are, as dietary supplements: nutrients and botanicals sold with honest labels and claims about supporting normal function. Some compounds sold as nootropics aren’t lawful supplements, such as phenibut and piracetam, and modafinil needs a prescription. You’re responsible for what’s in your products and what your pages say.
Are nootropics FDA approved?
No supplement is. FDA doesn’t approve dietary supplements or their structure/function claims before they’re sold; the firm must have substantiation for a claim and notify FDA of it within 30 days. A compound that would need approval as a drug, such as piracetam, can’t be sold as a supplement at all.
Can I sell racetams or noopept labelled “for research only”?
A label doesn’t decide it. FDA judges a product by how it’s marketed and who it’s sold to, and it has treated noopept and similar compounds as unapproved drugs. Railbed doesn’t check your catalogue, so take legal advice before you sell anything outside ordinary supplement ingredients.
Is phenibut legal to sell as a supplement?
Not in the US. FDA said in April 2019 that phenibut “does not meet the definition of a dietary ingredient”, so products labelled as supplements that list it are misbranded, and it sent warning letters to three companies selling them.
Is tianeptine legal to sell?
Not as a supplement anywhere in the US: FDA says it isn’t a dietary ingredient and is an unsafe food additive. As of December 2025, 20 states also listed it as a controlled substance and Maryland banned its sale, LAPPA reports.
Can I say my nootropic improves memory or focus?
A claim about supporting normal function, with substantiation, a notification to FDA and the required disclaimer, is the kind supplements may make. A claim that a product prevents cognitive decline, treats ADHD or helps with any disease is a drug claim. FDA and the FTC jointly warned a nootropics store over exactly that in 2019.
Can I sell nootropics on Amazon?
Some, under Amazon’s dietary supplement rules. Its drugs policy prohibits anything controlled under federal or state law, products FDA has called unapproved, and named ingredients such as Celastrus paniculatus, so check every product against its policy before you list it.
Can I sell subscriptions?
As multi-month supplies and reorders. Railbed doesn’t charge cards automatically, so sell three- and six-month supplies up front, and send an invoice when a supply runs low. Buyers who reorder on purpose don’t dispute charges they forgot about.
Do my buyers need crypto or a crypto wallet?
No. Buyers pay with the card they already have, on a normal checkout. The conversion to USDC happens after they pay, and only you need a wallet.
Will buyers be asked for ID when they pay?
Sometimes, and the card provider decides. Smart Routing sends each buyer to the provider least likely to ask for ID at their amount and location, so smaller orders often go through with little or no check.
What happens if a buyer disputes an order?
The dispute goes to the card provider that charged the buyer’s card, and a settled payment can’t be pulled back out of your wallet. There’s no chargeback fee for Railbed to pass on.
Can Railbed freeze my money?
No. Every paid order settles straight to a wallet you control, so there’s no balance with Railbed to hold. Railbed can stop new payments on an account only when the law requires it, and it can never touch USDC that has already reached your wallet.
What is the smallest order I can sell?
Card providers set minimums, and the smallest is about $2. Around $10 or more gives buyers the widest choice of providers, which is why a one-month supply or a trial pack works better than a single-dose sample.
Sources
- Fortune Business Insights: Nootropics market, 2026
- JAMA Internal Medicine: Presence of piracetam in cognitive enhancement dietary supplements, 25 November 2019
- Durango Merchant Services: Nutraceutical and supplement merchant accounts, modified 2 November 2026
- Stripe: Prohibited and restricted businesses, last updated 22 September 2026, checked 20 November 2026
- PayPal: Acceptable use policy, last updated 4 November 2026, checked 20 November 2026
- Shopify Help Center: Shopify Payments eligibility, and Shopify Community: payment gateway issues due to “pseudo-pharmaceuticals”, 7 March 2021
- FDA: Phenibut in dietary supplements, and FDA: Warning letter to Crystal Clear Supplements, 4 February 2022
- Legislative Analysis and Public Policy Association: Tianeptine fact sheet, December 2025
- PaymentCloud: Nootropics merchant account, modified 20 March 2026, and CERF: Nootropics merchant account, 8 November 2026
- LegitScript: Merchant category codes, 13 November 2024
- Merchant Risk Council: Stricter VAMP ratio thresholds are now in effect, 1 April 2026
- FDA: FDA acts on dietary supplements containing DMHA and phenibut, 16 April 2019, checked 20 November 2026
- FDA: Recent FDA action on dietary supplements labeled as containing picamilon, 30 November 2015, checked 20 November 2026
- FDA: Tianeptine products linked to serious harm, overdoses, death, 9 May 2025, checked 20 November 2026
- eCFR: 21 CFR 1308.14, Schedule IV, checked 20 November 2026
- FDA: Guidance for industry, highly concentrated caffeine in dietary supplements, April 2018, checked 20 November 2026
- FDA: Pure and highly concentrated caffeine, updated 6 March 2023, checked 20 November 2026
- FDA: Structure/function claims, updated 28 March 2024, checked 20 November 2026
- FDA: Warning letter to Pure Nootropics, LLC, 5 February 2019, checked 20 November 2026
- Amazon Seller Central: Drugs and drug paraphernalia, checked 20 November 2026
Last updated .
PaidA stack of three, settled to your wallet$72.00
Build the stack.
Nothing held back.
Set up in under a minute. Your first payment can settle today.
- Nothing held back
- No setup fee
- Settled sales stay yours
Moving a lot of volume? Talk to our team